New Delhi, Nov. 21 -- Shares of Balaxi Pharmaceuticals soared 10% in intraday trade on Friday, November 21, to Rs.39.5 apiece, defying the broader weakness on Dalal Street. Though the stock rebounded sharply in today's session, it is still down 11.50% so far in November.

The stock has been under severe selling pressure since May 2024, having closed 16 out of the following 18 months in the red, with February 2025 marking the biggest monthly drop of 21.51%, followed by October 2024, which saw a decline of 16%.

These deeper cuts have led the stock to lose 47.42% of its value so far this year, extending the previous years' losses of 17% in CY24 and 29% in CY23. The continued fall has erased significant wealth for retail investors, who colle...